It may be late but in reality they are a small company with limited capacity.
I think more than anything, if this does accurately provide a screening of COVID, then gives us another avenue to showcase and build on foundational technology.
What other respiratory diseases are left? And if the tech can pivot to do all these things including COVID, what is stopping it from being able to detect these other respiratory diseases.
For me this is less about jumping on covid bandwagon but proving the sheer flexibility of the product RAP has. There are multiple COVID tests so this may help penetration where they aren't already. I don't know how big this segment is so always take smallest view.
That being said, my focus is still the same as all other posts for commercilisation;
- Ilara Health outcome
- Medgate outcome
- Forums
- ASX - By Stock
- RAP
- Ann: Clinical study to develop COVID-19 screening test
Ann: Clinical study to develop COVID-19 screening test, page-22
-
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online